The GxP offering provides the “people, process and technology” of the DNAnexus managed components for our Customers to participate in regulated research (GLP), clinical trials (GCP), machine learning (GMLP) and manufacturing processes (GMP) with the regulators in their target countries. While “GxP” refers to the US regulations, the term is used generically to refer to other agencies, such as Medicines Health Products Regulatory Agency (MHRA), and European Medicines Agency (EMA). At present, the health regulatory agencies include the US, UK, and EU. Other countries, such as Australia, China, etc. are under discussion at this time.